“However, each case should be evaluated an individualised basis to account for potential bleeding risk.”
The drugs are commonly used to slow down clotting in patients at risk of a heart attack or stroke.
Previous research at the Icahn School of Medicine at Mount Sinai has identified life threatening clots in many hospitalised Covid-19 patients. These can cut off blood supply, causing a heart attack or stroke.
Co-researcher Dr Anu Lala, of the Icahn School of Medicine, said: “As a cardiologist who has been on service caring for Covid-19 patients for the last three weeks, I have observed an increased amount of blood clot cases among hospitalised patients.
“So it is critical to look at whether anticoagulants provide benefits for them. It is important to note further analysis and prospective studies are required to determine the effectiveness for widespread use of anticoagulants in hospitalised Covid-19 patients.”
No comments:
Post a Comment